Reduced quantity and function of pneumococcal antibodies are associated with exacerbations of COPD in SPIROMICS.
LaFon DC, Woo H, Fedarko N, Azar A, Hill H, Tebo AE, Martins TB, Han MK, Krishnan JA, Ortega VE, Barjaktarevic I, Kaner RJ, Hastie A, O'Neal WK, Couper D, Woodruff PG, Curtis JL, Hansel NN, Nahm MH, Dransfield MT, Putcha N; SPIROMICS investigators.
LaFon DC, et al.
Clin Immunol. 2023 May;250:109324. doi: 10.1016/j.clim.2023.109324. Epub 2023 Apr 6.
Clin Immunol. 2023.
PMID: 37030524
Free PMC article.